The Resistance Landscape of Abivertinib, a Third-Generation EGFR Tyrosine Kinase Inhibitor, and Clinical Strategy to Overcome Resistance in EGFR T790M-Positive Non-Small Cell Lung Cancer

2019 ◽  
Author(s):  
Yi-Chen Zhang ◽  
Zhi-Hong Chen ◽  
Xu-Chao Zhang ◽  
Chong-Rui Xu ◽  
Hong-Hong Yan ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Small Cell ◽  
Third Generation ◽  
Small Cell Lung ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr T790m ◽  
Clinical Strategy

Treatment Options for EGFR T790M-Negative EGFR Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer

2017 ◽  
Vol 12 (2) ◽  
pp. 153-161 ◽  
Author(s):  
Salvatore Corallo ◽  
Ettore D’Argento ◽  
Antonia Strippoli ◽  
Michele Basso ◽  
Santa Monterisi ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Tyrosine Kinase ◽  
Small Cell Lung Cancer ◽  
Tyrosine Kinase Inhibitor ◽  
Kinase Inhibitor ◽  
Treatment Options ◽  
Small Cell ◽  
Small Cell Lung ◽  
Egfr Tyrosine Kinase Inhibitor ◽  
Egfr T790m
Sign in / Sign up

Export Citation Format

Share Document